SuppreMol Wins .1M Funding for Clinical Development of Autoimmune Therapy - Genetic Engineering News

SuppreMol Wins .1M Funding for Clinical Development of Autoimmune Therapy Genetic Engineering News SuppreMol believes SM101 could also have utility in a range of autoimmune diseases including rheumatoid arthritis. Located in Martinsried, Germany, ... and more »

Dis-Jointed - Natural Products Industry Insider

Dis-Jointed Natural Products Industry Insider About 1 in every 250 children (under 18) has a form of arthritis or rheumatoid condition. Relative to gender, there is a slightly higher rate among women. ... and more »

FDA Questions Safety, Efficacy of Belimumab - MedPage Today

The Money Times

FDA Questions Safety, Efficacy of Belimumab MedPage Today ... marginal efficacy" of a novel rheumatoid arthritis drug with blockbuster potential outweighs the drug's possible risk of infection, cancer, and suicide. ... FDA Panel Backs Approval Of Human Genome, Glaxo Lupus DrugWall Street Journal Human Genome lupus drug's approval may spur takeover bidThe Star-Ledger - NJ.com Human Genome, Glaxo To Face FDA Panel For Lupus DrugWall Street Journal StreetInsider.com (subscription) (blog) -Wall Street Journal all 793 news articles »

ANN ARBOR: UM student receives scholarship for rheumatoid arthritis - Heritage Newspapers

ANN ARBOR: UM student receives scholarship for rheumatoid arthritis Heritage Newspapers The 2010 UCB Rheumatoid Arthritis Family Scholarship winners have been announced, and Ann Arbor resident and UM student Tiffany ...